fbpx

Consolidated Research: 2018 Summary Expectations for Microchip Technology, New Jersey Resources, Brown-Forman, Pacira Pharmaceuticals, Team, and Solaris Oilfield Infrastructure Fundamental Analysis, Key Performance Indications

NEW YORK, June 18, 2018 (GLOBE NEWSWIRE) — In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Microchip Technology Incorporated (NASDAQ:MCHP), New Jersey Resources Corporation (NYSE:NJR), Brown-Forman Corporation (NYSE:BF-B), Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX), Team, Inc. (NYSE:TISI), and Solaris Oilfield Infrastructure, Inc. (NYSE:SOI), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

MCHP DOWNLOAD: http://Fundamental-Markets.com/register/?so=MCHP
NJR DOWNLOAD: http://Fundamental-Markets.com/register/?so=NJR
BF-B DOWNLOAD: http://Fundamental-Markets.com/register/?so=BF-B
PCRX DOWNLOAD: http://Fundamental-Markets.com/register/?so=PCRX
TISI DOWNLOAD: http://Fundamental-Markets.com/register/?so=TISI
SOI DOWNLOAD: http://Fundamental-Markets.com/register/?so=SOI

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine Microchip Technology Incorporated (NASDAQ:MCHP), New Jersey Resources Corporation (NYSE:NJR), Brown-Forman Corporation (NYSE:BF-B), Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX), Team, Inc. (NYSE:TISI), and Solaris Oilfield Infrastructure, Inc. (NYSE:SOI) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today’s readers below.

—————————————–

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed June 14th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

—————————————–

MICROCHIP TECHNOLOGY INCORPORATED (MCHP) REPORT OVERVIEW

Microchip Technology’s Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, Microchip Technology reported revenue of $1,002.32MM vs $902.66MM (up 11.04%) and basic earnings per share $0.62 vs $0.63 (down 1.59%). For the twelve months ended March 31st, 2018 vs March 31st, 2017, Microchip Technology reported revenue of $3,980.80MM vs $3,407.80MM (up 16.81%) and basic earnings per share $1.10 vs $0.76 (up 44.74%). Microchip Technology is expected to report earnings on August 2nd, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $1.25. The estimated EPS forecast for the next fiscal year is $7.04 and is expected to report on May 14th, 2019.

To read the full Microchip Technology Incorporated (MCHP) report, download it here: http://Fundamental-Markets.com/register/?so=MCHP

—————————————–

NEW JERSEY RESOURCES CORPORATION (NJR) REPORT OVERVIEW

New Jersey Resources’ Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, New Jersey Resources reported revenue of $1,019.04MM vs $733.55MM (up 38.92%) and basic earnings per share $1.60 vs $1.33 (up 20.30%). For the twelve months ended September 30th, 2017 vs September 30th, 2016, New Jersey Resources reported revenue of $2,268.62MM vs $1,880.91MM (up 20.61%) and basic earnings per share $1.53 vs $1.53 (unchanged). New Jersey Resources is expected to report earnings on August 1st, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $0.20. The estimated EPS forecast for the next fiscal year is $2.00 and is expected to report on November 20th, 2018.

To read the full New Jersey Resources Corporation (NJR) report, download it here: http://Fundamental-Markets.com/register/?so=NJR

—————————————–

BROWN-FORMAN CORPORATION (BF-B) REPORT OVERVIEW

Brown-Forman’s Recent Financial Performance

For the three months ended April 30th, 2018 vs April 30th, 2017, Brown-Forman reported revenue of $733.00MM vs $695.00MM (up 5.47%) and basic earnings per share $0.24 vs $0.30 (down 20.27%). For the twelve months ended April 30th, 2018 vs April 30th, 2017, Brown-Forman reported revenue of $3,248.00MM vs $2,994.00MM (up 8.48%) and basic earnings per share $1.49 vs $1.38 (up 7.97%). Brown-Forman is expected to report earnings on August 29th, 2018. The report will be for the fiscal period ending July 31st, 2018. The reported EPS for the same quarter last year was $0.37. The estimated EPS forecast for the next fiscal year is $1.96 and is expected to report on June 5th, 2019.

To read the full Brown-Forman Corporation (BF-B) report, download it here: http://Fundamental-Markets.com/register/?so=BF-B

—————————————–

PACIRA PHARMACEUTICALS, INC. (PCRX) REPORT OVERVIEW

Pacira Pharmaceuticals’ Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, Pacira Pharmaceuticals reported revenue of $74.61MM vs $69.28MM (up 7.68%) and basic earnings per share -$0.26 vs -$0.52. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Pacira Pharmaceuticals reported revenue of $286.63MM vs $276.37MM (up 3.71%) and basic earnings per share -$1.07 vs -$1.02. Pacira Pharmaceuticals is expected to report earnings on August 1st, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was -$0.29. The estimated EPS forecast for the next fiscal year is -$0.62 and is expected to report on February 27th, 2019.

To read the full Pacira Pharmaceuticals, Inc. (PCRX) report, download it here: http://Fundamental-Markets.com/register/?so=PCRX

—————————————–

TEAM, INC. ? (TISI) REPORT OVERVIEW

Team’s Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, Team reported revenue of $302.39MM vs $286.55MM (up 5.52%) and basic earnings per share -$0.60 vs -$0.32. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Team reported revenue of $1,200.21MM vs $1,196.70MM (up 0.29%) and basic earnings per share -$3.49 vs -$0.45. Team is expected to report earnings on August 6th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was -$0.23. The estimated EPS forecast for the next fiscal year is $0.41 and is expected to report on March 12th, 2019.

To read the full Team, Inc. (TISI) report, download it here: http://Fundamental-Markets.com/register/?so=TISI

—————————————–

SOLARIS OILFIELD INFRASTRUCTURE, INC. (SOI) REPORT OVERVIEW

Solaris Oilfield Infrastructure’s Recent Financial Performance

Solaris Oilfield Infrastructure is expected to report earnings on August 2nd, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $0.41. The estimated EPS forecast for the next fiscal year is $2.62 and is expected to report on March 5th, 2019.

To read the full Solaris Oilfield Infrastructure, Inc. (SOI) report, download it here: http://Fundamental-Markets.com/register/?so=SOI

—————————————–

ABOUT FUNDAMENTAL MARKETS

Fundamental Markets serves thousands of members and have provided research through some of the world’s leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets’ roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets’ oversight and audit staff are registered analysts, brokers, and/or financial advisers (“Registered Members”) working within Equity Research, Media, and Compliance departments. Fundamental Markets’ roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets’ Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: media@Fundamental-Markets.com

© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.

Primary Logo